Nathan (USA) Diagnosed with AHP First Quarter 2023 Financial Results May 4, 2023 1© 2023 Alnylam Pharmaceuticals, Inc. Agenda Welcome • Christine Lindenboom Senior Vice President, Investor Relations & Corporate Communications Overview • Yvonne Greenstreet, MBChB, MBA Chief Executive Officer Commercial Highlights • Tolga Tanguler Chief Commercial Officer Alnylam Pipeline • Akshay Vaishnaw, M.D., Ph.D. President Financial Summary and Upcoming Milestones • Jeff Poulton Chief Financial Officer Q&A Session 2 Aln ...